882 related articles for article (PubMed ID: 27096382)
1. Therapeutic Efficacy of Interleukin 12/Interleukin 23 Blockade in Generalized Pustular Psoriasis Regardless of IL36RN Mutation Status.
Arakawa A; Ruzicka T; Prinz JC
JAMA Dermatol; 2016 Jul; 152(7):825-8. PubMed ID: 27096382
[TBL] [Abstract][Full Text] [Related]
2. Association of IL36RN mutations with clinical features, therapeutic response to acitretin, and frequency of recurrence in patients with generalized pustular psoriasis.
Zhu T; Jin H; Shu D; Li F; Wu C
Eur J Dermatol; 2018 Apr; 28(2):217-224. PubMed ID: 29619998
[TBL] [Abstract][Full Text] [Related]
3. Clinical profiles of pediatric patients with GPP alone and with different IL36RN genotypes.
Wang Y; Cheng R; Lu Z; Guo Y; Yan M; Liang J; Huang P; Li M; Yao Z
J Dermatol Sci; 2017 Mar; 85(3):235-240. PubMed ID: 28063630
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment with interleukin-17A antagonists of generalized pustular psoriasis in patients without IL36RN mutations.
Wilsmann-Theis D; Schnell LM; Ralser-Isselstein V; Bieber T; Schön MP; Hüffmeier U; Mössner R
J Dermatol; 2018 Jul; 45(7):850-854. PubMed ID: 29655177
[TBL] [Abstract][Full Text] [Related]
5. Different Clinical Features of Pediatric Generalized Pustular Psoriasis in Patients with or without IL36RN Variants.
Wang Z; Xiang X; Chen Y; Qi Z; Miao C; Liu Y; Zhao X; Zhang Y; Zhang Z; Li W; Xu Z; Ma L
Dermatology; 2023; 239(2):217-226. PubMed ID: 36577391
[TBL] [Abstract][Full Text] [Related]
6. Juvenile generalized pustular psoriasis is a chronic recalcitrant disease: an analysis of 27 patients seen in a tertiary hospital in Johor, Malaysia.
Lau BW; Lim DZ; Capon F; Barker JN; Choon SE
Int J Dermatol; 2017 Apr; 56(4):392-399. PubMed ID: 28194751
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of refractory juvenile generalized pustular psoriasis with secukinumab monotherapy: A case report and review of published work.
Ho PH; Tsai TF
J Dermatol; 2018 Nov; 45(11):1353-1356. PubMed ID: 30230584
[TBL] [Abstract][Full Text] [Related]
8. Juvenile generalized pustular psoriasis with IL36RN mutation treated with short-term infliximab.
Pan J; Qiu L; Xiao T; Chen HD
Dermatol Ther; 2016 May; 29(3):164-7. PubMed ID: 26627198
[TBL] [Abstract][Full Text] [Related]
9. Gastrointestinal bleeding with severe mucosal involvement in a patient with generalized pustular psoriasis without IL36RN mutation.
Komatsuda S; Kamata M; Chijiwa C; Namiki K; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Abe K; Yamamoto T; Aozasa N; Sugiura K; Tada Y
J Dermatol; 2019 Jan; 46(1):73-75. PubMed ID: 30474867
[TBL] [Abstract][Full Text] [Related]
10. Acrodermatitis continua of Hallopeau treated successfully with ustekinumab and acitretin after failure of tumour necrosis factor blockade and anakinra.
Saunier J; Debarbieux S; Jullien D; Garnier L; Dalle S; Thomas L
Dermatology; 2015; 230(2):97-100. PubMed ID: 25471551
[TBL] [Abstract][Full Text] [Related]
11. Treatment Options and Goals for Patients with Generalized Pustular Psoriasis.
Krueger J; Puig L; Thaçi D
Am J Clin Dermatol; 2022 Jan; 23(Suppl 1):51-64. PubMed ID: 35061230
[TBL] [Abstract][Full Text] [Related]
12. The genetic background of generalized pustular psoriasis: IL36RN mutations and CARD14 gain-of-function variants.
Sugiura K
J Dermatol Sci; 2014 Jun; 74(3):187-92. PubMed ID: 24656634
[TBL] [Abstract][Full Text] [Related]
13. Mutation analysis of the IL36RN gene in Chinese patients with generalized pustular psoriasis with/without psoriasis vulgaris.
Li X; Chen M; Fu X; Zhang Q; Wang Z; Yu G; Yu Y; Qin P; Wu W; Pan F; Liu H; Zhang F
J Dermatol Sci; 2014 Nov; 76(2):132-8. PubMed ID: 25212972
[TBL] [Abstract][Full Text] [Related]
14. Expression of interleukin-36 receptor antagonist in a patient with generalized pustular psoriasis harboring the p.Pro82Leu variant in the IL36RN gene.
Mizukawa I; Kamata M; Shimizu T; Ito M; Watanabe A; Uchida H; Egawa S; Nagata M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Sugiura K; Tada Y
J Dermatol; 2023 Dec; 50(12):1608-1613. PubMed ID: 37525499
[TBL] [Abstract][Full Text] [Related]
15. The genetic basis for most patients with pustular skin disease remains elusive.
Mössner R; Wilsmann-Theis D; Oji V; Gkogkolou P; Löhr S; Schulz P; Körber A; Prinz JC; Renner R; Schäkel K; Vogelsang L; Peters KP; Philipp S; Reich K; Ständer H; Jacobi A; Weyergraf A; Kingo K; Kõks S; Gerdes S; Steinz K; Schill T; Griewank KG; Müller M; Frey S; Ebertsch L; Uebe S; Sticherling M; Sticht H; Hüffmeier U
Br J Dermatol; 2018 Mar; 178(3):740-748. PubMed ID: 28887889
[TBL] [Abstract][Full Text] [Related]
16. [Genetic Polymorphism of IL36RN in Han Patients with Generalized Pustular Psoriasis Alone in Sichuan Region].
Li ZT; Wang S
Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jul; 49(4):582-586. PubMed ID: 30378314
[TBL] [Abstract][Full Text] [Related]
17. Increased neutrophil-derived IL-17A identified in generalized pustular psoriasis.
Lan Y; Wu X; Zhong X; Song P; Liu L; Liu Y; Ai X; Han C; Zhang Z
Exp Dermatol; 2024 Feb; 33(2):e15026. PubMed ID: 38414093
[TBL] [Abstract][Full Text] [Related]
18. Correlation of IL36RN and CARD14 mutations with clinical manifestations and laboratory findings in patients with generalised pustular psoriasis.
Trai NN; Van Em D; Van BT; My LH; Van Tro C; Hao NT; Vu HA; Tram DB; Van Thuong N; Doanh LH
Indian J Dermatol Venereol Leprol; 2023; 89(3):378-384. PubMed ID: 36331855
[TBL] [Abstract][Full Text] [Related]
19. Whole exome sequencing approach to childhood onset familial erythrodermic psoriasis unravels a novel mutation of CARD14 requiring unusual high doses of ustekinumab.
Signa S; Campione E; Rusmini M; Chiesa S; Grossi A; Omenetti A; Caorsi R; Viglizzo GM; Galluzzo M; Bianchi L; Talamonti M; Orlandi A; Martini A; Ceccherini I; Gattorno M
Pediatr Rheumatol Online J; 2019 Jul; 17(1):38. PubMed ID: 31286971
[TBL] [Abstract][Full Text] [Related]
20. Rapid downregulation of innate immune cells, interleukin-12 and interleukin-23 in generalized pustular psoriasis with infliximab in combination with acitretin.
Tang MM; Spanou Z; Tang H; Schibler F; Pelivani N; Yawalkar N
Dermatology; 2012; 225(4):338-43. PubMed ID: 23343611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
